(Stroke. 1997;28:2557-2562.)
© 1997 American Heart Association, Inc.
Articles |
Effect of Antihypertensive Treatment in Patients Having Already Suffered From Stroke
Gathering the Evidence
From the Clinical Pharmacology Department (F.G., J-P.B, F.B.), Claude Bernard University, Lyon Hospitals, France; London School of Hygiene and Tropical Medicine (S.P.), London, UK; General practice (J.C.), Bollington, UK; National Heart, Lung, and Blood Institute (J.C., L.F., E.S.), National Institutes of Health, Bethesda, MD; Department of Community Health Sciences (T.E.), Dalby/Lund, Sweden; Hypertension and Cardiovascular Rehabilitation Unit (R.F.), Leuven, Belgium; Veterans Administration Medical Center (K.K.), San Francisco, Calif; Washington University School of Medicine (M.P.), St Louis, MO; and Department of Epidemiology and Public Health (R.P.), Miami, Fla.
Correspondence to Dr François Gueyffier, Service de Pharmacologie Clinique - 162 Avenue Lacassagne - BP 3041, 69 394 LYON Cedex 03, France. E-mail fg{at}upcl.univ-lyon1.fr
Background and Purpose Drug treatment of high blood pressure has been shown to reduce the associated cardiovascular risk. Stroke represents the type of event more strongly linked with high blood pressure, responsible for a high rate of death or invalidity, and with the highest proportion of events that can be avoided by treatment. Hypertensive patients with a history of cerebrovascular accident are at particularly high risk of recurrence. Specific trials of blood pressure lowering drugs in stroke survivors showed inconclusive results in the past.
Methods We performed a meta-analysis using all available randomized controlled clinical trials assessing the effect of blood pressure lowering drugs on clinical outcomes (recurrence of stroke, coronary events, cause-specific, and overall mortality) in patients with prior stroke or transient ischemic attack.
Results We identified 9 trials, including a total of 6752 patients: 2 trials included 551 hypertensive stroke survivors; 6 trials of hypertensive patients included a small proportion of stroke survivors (536 patients); 1 trial included stroke survivors, whether hypertensive or not (5665 patients). The recurrence of stroke, fatal and nonfatal, was significantly reduced in active groups compared with control groups consistently across the different sources of data (relative risk of 0.72, 95% confidence interval: 0.61 to 0.85). There was no evidence that this intervention induced serious adverse effect.
Conclusions Blood pressure lowering drug interventions reduced the risk of stroke recurrence in stroke survivors. Available data did not allow to verify whether such benefit depends on initial blood pressure level. More data are needed before considering antihypertensive therapy in normotensive patients at high cerebrovascular risk.
Key Words: antihypertensive agents • clinical trials • hypertension • meta-analysis • stroke prevention
This article has been cited by other articles:
 |
|
 |
|
  T. Kurth and C. Tzourio Treating Patients With Ischemic Stroke With Tissue Plasminogen Activator in the 3.5- to 4-Hour Window: Numbers Support Benefit but the Message Is to Still Go Fast Stroke, July 1, 2009; 40(7): 2295 - 2296. [Full Text] [PDF]
|
|
|
|
 |
|
 R. Raine, W. Wong, G. Ambler, S. Hardoon, I. Petersen, R. Morris, M. Bartley, and D. Blane Sociodemographic variations in the contribution of secondary drug prevention to stroke survival at middle and older ages: cohort study BMJ, April 16, 2009; 338(apr16_2): b1279 - b1279. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.A. Harbison, S. Walsh, and R.A. Kenny Hypertension and daytime hypotension found on ambulatory blood pressure is associated with fatigue following stroke and TIA QJM, February 1, 2009; 102(2): 109 - 115. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. I. Qureshi Acute Hypertensive Response in Patients With Stroke: Pathophysiology and Management Circulation, July 8, 2008; 118(2): 176 - 187. [Full Text] [PDF]
|
|
|
|
 |
|
 A Arboix, A Font, C Garro, L Garcia-Eroles, E Comes, and J Massons Recurrent lacunar infarction following a previous lacunar stroke: a clinical study of 122 patients J. Neurol. Neurosurg. Psychiatry, December 1, 2007; 78(12): 1392 - 1394. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. N. Turan, G. Cotsonis, M. J. Lynn, S. Chaturvedi, M. Chimowitz, and for the Warfarin-Aspirin Symptomatic Intracranial Relationship Between Blood Pressure and Stroke Recurrence in Patients With Intracranial Arterial Stenosis Circulation, June 12, 2007; 115(23): 2969 - 2975. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. S. Kirshner, J. Biller, and A. S. Callahan III Long-Term Therapy to Prevent Stroke J Am Board Fam Med, November 1, 2005; 18(6): 528 - 540. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Ovbiagele, N. K. Hills, J. L. Saver, and S. C. Johnston Antihypertensive Medications Prescribed at Discharge After an Acute Ischemic Cerebrovascular Event Stroke, September 1, 2005; 36(9): 1944 - 1947. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. E. Strandberg Editorial Comment: Secondary Prevention of Stroke Is Important: But All Hypertensive Drugs Are Not Created Equal? Stroke, June 1, 2005; 36(6): 1225 - 1226. [Full Text] [PDF]
|
|
|
|
 |
|
 K. D. Flemming and R. D. Brown Jr Secondary Prevention Strategies in Ischemic Stroke: Identification and Optimal Management of Modifiable Risk Factors Mayo Clin. Proc., October 1, 2004; 79(10): 1330 - 1340. [Abstract] [PDF]
|
|
|
|
 |
|
 E. Neri, G. Sani, M. Massetti, G. Frati, D. Buklas, R. Tassi, M. Giubbolini, A. Benvenuti, and C. Sassi Residual dissection of the brachiocephalic arteries: Significance, management, and long-term outcome J. Thorac. Cardiovasc. Surg., August 1, 2004; 128(2): 303 - 312. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. I. Sokol, E. L. Portnay, J. P. Curtis, M. A. Nelson, P. R. Hebert, J. F. Setaro, and J. M. Foody Modulation of the renin-angiotensin-aldosterone system for the secondary prevention of stroke Neurology, July 27, 2004; 63(2): 208 - 213. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Amar, J. P. Cambou, E. Touze, V. Bongard, G. Jullien, A. Vahanian, G. Coppe, J. L. Mas, and on behalf of ECLAT1 Study Investigators Comparison of Hypertension Management After Stroke and Myocardial Infarction: Results From ECLAT1--A French Nationwide Study Stroke, July 1, 2004; 35(7): 1579 - 1583. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Rashid, J. Leonardi-Bee, and P. Bath Blood Pressure Reduction and Secondary Prevention of Stroke and Other Vascular Events: A Systematic Review Stroke, November 1, 2003; 34(11): 2741 - 2748. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P.M. Rothwell, S.C. Howard, and J.D. Spence Relationship Between Blood Pressure and Stroke Risk in Patients With Symptomatic Carotid Occlusive Disease Stroke, November 1, 2003; 34(11): 2583 - 2590. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Oliveira-Filho, S.C.S. Silva, C.C. Trabuco, B.B. Pedreira, E.U. Sousa, and A. Bacellar Detrimental effect of blood pressure reduction in the first 24 hours of acute stroke onset Neurology, October 28, 2003; 61(8): 1047 - 1051. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Harrington Managing Hypertension in Patients With Stroke: Are You Prepared for Labetalol Infusion? Crit. Care Nurse, June 1, 2003; 23(3): 30 - 38. [Full Text] [PDF]
|
|
|
|
 |
|
 R Mc Govern and A Rudd Management of stroke Postgrad. Med. J., February 1, 2003; 79(928): 87 - 92. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. C. Johnston Transient Ischemic Attack N. Engl. J. Med., November 21, 2002; 347(21): 1687 - 1692. [Full Text] [PDF]
|
|
|
|
|
|
G. Friday, M. Alter, and S.-M. Lai Control of Hypertension and Risk of Stroke Recurrence Stroke, November 1, 2002; 33(11): 2652 - 2657. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. E. Straus, S. R. Majumdar, and F. A. McAlister New Evidence for Stroke Prevention: Scientific Review JAMA, September 18, 2002; 288(11): 1388 - 1395. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M R Law and N J Wald Risk factor thresholds: their existence under scrutiny BMJ, June 29, 2002; 324(7353): 1570 - 1576. [Full Text] [PDF]
|
|
|
|
|
|
M. S. Mouradian, S. R. Majumdar, A. Senthilselvan, K. Khan, and A. Shuaib How Well Are Hypertension, Hyperlipidemia, Diabetes, and Smoking Managed After a Stroke or Transient Ischemic Attack? Stroke, June 1, 2002; 33(6): 1656 - 1659. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. B. Gorelick Stroke Prevention Therapy Beyond Antithrombotics: Unifying Mechanisms in Ischemic Stroke Pathogenesis and Implications for Therapy: An Invited Review Stroke, March 1, 2002; 33(3): 862 - 875. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. van Gijn The PROGRESS Trial: Preventing Strokes by Lowering Blood Pressure in Patients With Cerebral Ischemia: Emerging Therapies: Critique of an Important Advance Stroke, January 1, 2002; 33(1): 319 - 320. [Full Text] [PDF]
|
|
|
|
 |
|
 F. J He and G. A MacGregor Blood pressure and stroke; the PROGRESS trial Journal of Renin-Angiotensin-Aldosterone System, September 1, 2001; 2(3): 153 - 155. [PDF]
|
|
|
|
|
|
T. Sappok, A. Faulstich, E. Stuckert, H. Kruck, P. Marx, and H.-C. Koennecke Compliance With Secondary Prevention of Ischemic Stroke: A Prospective Evaluation Stroke, August 1, 2001; 32(8): 1884 - 1889. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. H. Dobkin, C. J. M. Klijn, L. J. Kappelle, A. C. van Huffelen, G. H. Visser, A. Algra, C. A. F. Tulleken, and J. van Gijn Recurrent ischemia in symptomatic carotid occlusion: Prognostic value of hemodynamic factors Neurology, July 10, 2001; 57(1): 161 - 162. [Full Text] [PDF]
|
|
|
|
|
|
G. Gubitz and P. Sandercock Regular review: Prevention of ischaemic stroke BMJ, December 9, 2000; 321(7274): 1455 - 1459. [Full Text]
|
|
|
|
|
|
W. N. Kernan, C. M. Viscoli, L. M. Brass, R. W. Makuch, P. M. Sarrel, and R. I. Horwitz Blood Pressure Exceeding National Guidelines Among Women After Stroke Stroke, February 1, 2000; 31(2): 415 - 419. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Hillen, R. Dundas, E. Lawrence, J. A. Stewart, A. G. Rudd, and C. D. A. Wolfe Antithrombotic and Antihypertensive Management 3 Months After Ischemic Stroke : A Prospective Study in an Inner City Population Stroke, February 1, 2000; 31(2): 469 - 475. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. D. Feldman, N. Campbell, P. Larochelle, P. Bolli, E. D. Burgess, S. G. Carruthers, J. S. Floras, R. B. Haynes, G. Honos, F. H.H. Leenen, et al. 1999 Canadian recommendations for the management of hypertension Can. Med. Assoc. J., December 14, 1999; 161(90120): S1 - 17. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. J. Hankey Stroke: How Large a Public Health Problem, and How Can the Neurologist Help? Arch Neurol, June 1, 1999; 56(6): 748 - 754. [Abstract] [Full Text] [PDF]
|
|